AUB-HAS2 Cardiovascular Risk Index: Performance in Surgical Subpopulations and Comparison to the Revised Cardiac Risk

Habib A Dakik1, Eman Sbaity2, Ahmad Msheik1

  • 1Department of Internal Medicine American University of Beirut Medical Center Beirut Lebanon.

Insights

The new American University of Beirut-HAS2 Cardiovascular Risk Index (AUB-HAS2) offers superior preoperative risk assessment for noncardiac surgery compared to the Revised Cardiac Risk Index, improving patient stratification.

Area of Science:

  • Cardiology
  • Surgical Risk Assessment
  • Health Services Research

Background:

  • The American University of Beirut-HAS2 Cardiovascular Risk Index (AUB-HAS2) is a novel tool for preoperative cardiovascular risk evaluation.
  • It incorporates six key clinical factors: cardiac history, angina/dyspnea symptoms, age over 75, low hemoglobin, and vascular/emergency surgery status.

Purpose of the Study:

  • To evaluate the performance of the AUB-HAS2 index.
  • To compare its effectiveness against the Revised Cardiac Risk Index (RCRI) across diverse surgical populations.

Main Methods:

  • Analysis of 1,167,278 noncardiac surgeries from the American College of Surgeons National Surgical Quality Improvement Program database.
  • Risk stratification using the AUB-HAS2 score (0 to >3) based on the presence of the six elements.
  • Comparison of AUB-HAS2 and RCRI performance using receiver operating characteristic curves.

Main Results:

  • The AUB-HAS2 index effectively stratified risk across all surgical subgroups (P<0.001).
  • Patients with an AUB-HAS2 score of 0 exhibited a low event rate (<0.5%) in most surgeries.
  • AUB-HAS2 demonstrated superior discriminatory power compared to RCRI across all subgroups (P<0.001).

Conclusions:

  • The AUB-HAS2 index is validated across a wide range of surgical subpopulations.
  • It offers enhanced predictive accuracy for 30-day postoperative mortality, myocardial infarction, or stroke.
  • The AUB-HAS2 index represents an improvement over the RCRI for preoperative cardiovascular risk assessment.

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
689
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
528
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
273
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
288
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
437